• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
WealthTrack

WealthTrack

The right track to your financial health.

  • WATCH WEALTHTRACK
    • RECENT PROGRAMS
    • PODCASTS
    • STATION FINDER
  • WEB FEATURES
    • PODCASTS
    • SOCIAL NETWORKING
    • NEWSLETTER
  • WEALTHTRACK WOMEN
  • ABOUT
    • ABOUT CONSUELO
    • CONTACT US
    • NEWSLETTER
    • STATION FINDER

episode_1342

CONSIDER SOME HIGH ACTIVE SHARE FUNDS WITH LOW TURNOVER

CONSIDER SOME HIGH ACTIVE SHARE FUNDS WITH LOW TURNOVER Most investors moving into passive index funds Contrarian move would be to own a few actively managed funds Add low turnover as a criteria Watch the related WEALTHTRACK episode.

CONTRARIAN INVESTOR BILL MILLER DISCUSSES SOME OF HIS MOST CONTROVERSIAL HOLDINGS, INCLUDING VALEANT PHARMACEUTICALS

Legendary investor Bill Miller has always been an independent thinker and investor with a 100% “active share” in his funds, as different from any benchmark index as you can be. He is also now his own boss, having recently purchased 100% of his fund business from his long time employer Legg Mason and establishing his own investment advisory firm, Miller Value Partners. His two funds now bear his name and carry on his contrarian tradition of concentrated holdings in largely unloved stocks. His flagship Miller Opportunity Trust was the number one U.S. stock fund for the five year period ended in 2016. In a rare interview Miller gives his rationale for some of his most controversial holdings, including Valeant Pharmaceuticals.

WATCH NOW…

Bill Miller – Independent Investor

This page is here for technical reasons. Please click here for the episode page.

Primary Sidebar

Our Sponsors










Get the weekly newsletter from Consuelo Mack

WEALTHTRACK IS PRESENTED BY

discover

Footer

    • RECENT PROGRAMS
    • WEB EXTRA
    • PODCASTS
    • STATION FINDER
    • WEALTHTRACK WOMEN
    • WEB EXTRA
    • PODCASTS
    • SOCIAL NETWORKING
    • NEWSLETTER

 

Subscribe via RSS Feed Follow Me on Twitter Connect on Facebook

    • ABOUT CONSUELO
    • CONTACT US
    • NEWSLETTER
    • STATION FINDER

© 2025 MackTrack, Inc. All rights reserved.